Dectin-1 stimulating β -glucans inhibit Chlamydia infections both in vitro and in vivo
Pathogens and Disease · 2025
DOI: 10.1093/femspd/ftaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens and Disease, 2025. Verfasst von Jennifer Kintner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA. Hauptthemen laut MEDLINE: Chlamydia Infections, Lectins, C-Type, Candida albicans, beta-Glucans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Chlamydia trachomatis and Candida albicans are common inhabitants of the female genital tract. Candida albicans can impact the viability and pathogenesis of some bacteria. Previously, we investigated physical interactions between Ch. trachomatis elementary bodies (EBs) and Ca. albicans. This work indicated that EBs bind to Ca. albicans and become noninfectious by 24 h post-binding. Here, we continue our investigation of these interkingdom, polymicrobial interactions. Candida albicans adheres to bacteria or host surfaces via agglutinin-like sequence or heat shock 70 (Ssa) proteins. Chlamydia trachomatis EBs did not bind Ca. albicans Ssa2 deficient strains as efficiently as wild-type or complemented strains, indicating a role for this protein in chlamydial adherence to Candida. Additionally, Ca. albicans β-glucans inhibit chlamydial infection when exposure occurs during EB adsorption onto cervical cells. Laminarin, a β-glucan agonist of the C-type lectin receptor Dectin-1, inhibited chlamydial infection in both cervical epithelial cells and mice when exposure occurred prior to, during, or immediately following EB inoculation. Conversely, a Dectin-1 antagonist laminarin did not inhibit infection in vitro, suggesting that β-glucan inhibition of Ch. trachomatis requires C-type lectin receptor signaling. Overall, our data demonstrate that β-glucans from multiple species, including Ca. albicans, inhibit Chlamydia via stimulation of host-signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA.
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA.
- Department of Surgery, East Tennessee State University, Johnson City, TN 37614, USA.
- Department of Medical Education at Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.
ORCID-Profile: Jennifer V Hall
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kintner, J., Callaghan, M., Bulawa, L., Chu, A., Ma, Z., Williams, D. L., Schoborg, R. V., Kruppa, M. D., & Hall, J. V. (2025). Dectin-1 stimulating β -glucans inhibit Chlamydia infections both in vitro and in vivo. Pathogens and Disease. https://doi.org/10.1093/femspd/ftaf002
Vancouver
Kintner J, Callaghan M, Bulawa L, Chu A, Ma Z, Williams DL, et al. Dectin-1 stimulating β -glucans inhibit Chlamydia infections both in vitro and in vivo. Pathogens and Disease. 2025. doi:10.1093/femspd/ftaf002
BibTeX
@article{Kintner2025,
author = {Kintner, Jennifer and Callaghan, Morgan and Bulawa, Lillith and Chu, Angela and Ma, Zuchao and Williams, David L and Schoborg, Robert V and Kruppa, Michael D and Hall, Jennifer V},
title = {Dectin-1 stimulating β -glucans inhibit Chlamydia infections both in vitro and in vivo},
journal = {Pathogens and Disease},
year = {2025},
doi = {10.1093/femspd/ftaf002}
}
EUVIMED